The Evolving Role of Whole Breast Hypofractionation in Older Patients With Early Breast Cancer

被引:2
|
作者
Kunkler, Ian [1 ]
机构
[1] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Scotland
关键词
RADIOTHERAPY HYPOFRACTIONATION; RADIATION-THERAPY; SCHEDULES;
D O I
10.1016/j.semradonc.2021.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer in older patients presents an increasing health care challenge. Hypofractionated dose schedules of 15/16 daily fractions of postoperative radiotherapy over 3/3.5 weeks have been established in clinical trials with long term follow up as safe and effective and become the standard of care after breast conserving therapy for most older patients. Emerging clinical trial data are pushing the limits of hypofractionation to even shorter schedules over a week. In this mini-review the applicability of this new data to older patients is discussed and the development of guidelines for hypofractionated dose fractionation schedules adapted to the COVID19 pandemic for this age group. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 50 条
  • [1] Hypofractionation is a proven safe and effective modality for postoperative whole-breast radiotherapy for early breast cancer patients
    Brown, Stephen L.
    Rodger, Alan
    Orton, Colin G.
    MEDICAL PHYSICS, 2009, 36 (06) : 1927 - 1930
  • [2] Radiotherapy hypofractionation in early breast cancer
    Tsubokura, Masaharu
    Miura, Yuji
    Takei, Naoko
    Kami, Masahiro
    Komatsu, Tsunehiko
    LANCET, 2008, 372 (9634): : 204 - 204
  • [3] Hypofractionation with no boost after breast conservation in early-stage breast cancer patients
    Arcadipane, Francesca
    Franco, Pierfrancesco
    De Colle, Chiara
    Rondi, Nadia
    Di Muzio, Jacopo
    Pelle, Emanuela
    Martini, Stefania
    Ala, Ada
    Airoldi, Mario
    Donadio, Michela
    De Sanctis, Corrado
    Castellano, Isabella
    Ragona, Riccardo
    Ricardi, Umberto
    MEDICAL ONCOLOGY, 2016, 33 (10)
  • [4] Hypofractionation with no boost after breast conservation in early-stage breast cancer patients
    Francesca Arcadipane
    Pierfrancesco Franco
    Chiara De Colle
    Nadia Rondi
    Jacopo Di Muzio
    Emanuela Pelle
    Stefania Martini
    Ada Ala
    Mario Airoldi
    Michela Donadio
    Corrado De Sanctis
    Isabella Castellano
    Riccardo Ragona
    Umberto Ricardi
    Medical Oncology, 2016, 33
  • [5] Radiotherapy hypofractionation in early breast cancer - Reply
    Yarnold, John
    LANCET, 2008, 372 (9634): : 205 - 205
  • [6] Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study
    Sigaudi, Valeria
    Zannetti, Micol
    Ferrara, Eleonora
    Manfredda, Irene
    Mones, Eleonora
    Loi, Gianfranco
    Krengli, Marco
    Franco, Pierfrancesco
    BIOMEDICINES, 2022, 10 (10)
  • [7] The evolving role of zoledronic acid in early breast cancer
    Gnant, Michael
    ONCOTARGETS AND THERAPY, 2009, 2 : 95 - 104
  • [8] The evolving role of proteomics in the early detection of breast cancer
    Pawlik, TM
    Kuerer, HM
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2005, 50 (05) : 212 - 216
  • [9] The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer
    Mitchel Barry
    Alice Ho
    Monica Morrow
    Annals of Surgical Oncology, 2013, 20 : 2534 - 2540
  • [10] The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer
    Barry, Mitchel
    Ho, Alice
    Morrow, Monica
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2534 - 2540